Carmeda AB

The advent of drug-eluting stents has increased the partnering visibility for companies with biocoatings. Ten years ago, SurModics Inc. , one of the few sizeable "pure play" companies in the biocoa

Coated stents may be a simple way to provide local, sustained-release drug delivery to combat restenosis, but the realities of development are complicated and costly. by Mary Stuart Restenosis—the ten